John H. Stewart named center director of LSU Health New Orleans/LCMC Health Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

John H. Stewart was named center director of the LSU Health New Orleans/LCMC Health Cancer Center. 

He will also join the LSU Health New Orleans School of Medicine faculty as a professor of surgery.

Stewart will set the overall mission, vision and direction for multidisciplinary cancer care and cancer clinical research programs for LSU Health New Orleans and LCMC Health in his new leadership role. 

He and his team will develop a robust cancer clinical trials program, leverage resources to build an innovative targeted cancer research enterprise and create a comprehensive community outreach and engagement program to reduce cancer risk behaviors and cancer incidence. 

Initiatives will integrate disease-specific research and care delivery into a comprehensive patient-oriented approach to benefit patients of Louisiana and surrounding regions, including those currently underserved in accessing leading-edge cancer care.

Stewart, originally from Shreveport, was recruited from the University of Illinois College of Medicine in Chicago. There, he was a University of Illinois Presidential Scholar, professor of surgery in the College of Medicine, deputy director of the University of Illinois Cancer Center, and physician executive for oncology sciences at the University of Illinois Health.

Stewart’s role will be effective July 1.

Table of Contents

YOU MAY BE INTERESTED IN

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January. 
A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login